Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Gross Margin (2018 - 2026)

TELA Bio has reported Gross Margin over the past 8 years, most recently at 65.91% for Q4 2025.

  • For Q4 2025, Gross Margin rose 233.0% year-over-year to 65.91%; the TTM value through Dec 2025 reached 67.69%, up 61.0%, while the annual FY2025 figure was 67.69%, 61.0% up from the prior year.
  • Gross Margin for Q4 2025 was 65.91% at TELA Bio, down from 67.52% in the prior quarter.
  • Over five years, Gross Margin peaked at 70.38% in Q2 2023 and troughed at 58.96% in Q1 2021.
  • A 5-year average of 66.35% and a median of 67.54% in 2025 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: surged 785bps in 2021 and later tumbled -481bps in 2024.
  • Year by year, Gross Margin stood at 67.58% in 2021, then increased by 4bps to 70.35% in 2022, then dropped by -3bps to 68.38% in 2023, then fell by -7bps to 63.58% in 2024, then rose by 4bps to 65.91% in 2025.
  • Business Quant data shows Gross Margin for TELA at 65.91% in Q4 2025, 67.52% in Q3 2025, and 69.84% in Q2 2025.